Surmodics Inc (NASDAQ: SRDX). Extremely significant negative changes in fundamentals have recently occurred: the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for September, 2026 decreased significantly, and significant quarterly sales deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Surmodics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Surmodics has a slightly negative Power Rating of 31 and a very low Appreciation Score of 9, leading to the Lowest Value Trend Rating.
Recent Price Action
Surmodics Inc (NASDAQ: SRDX) stock closed at $34.05 on 2/7/25 after a slight decline of -0.03%. Moreover, above average trading volume at 138% of normal accompanied the decline. The stock has declined -4.0% during the last week and has been weak relative to the market over the last nine months.
Be the first to comment